the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Appeal by Ziana Zain’s ex-husband against conviction for caning son to be heard on Sept 15

SHAH ALAM: The appeal by Armin Zaharin Ahmad Zambri, the ex-husband of famous singer Ziana Zain, to set aside his conviction and eight months’ jail sentence for caning his son will be heard on Sept 15.

Deputy public prosecutor, Shukor Abu Bakar said the appeal would be heard before High Court judge, Hasbullah Adam.

“The court ordered the prosecution, as the respondent, and the appellant (Armin Zaharin) to file their respective submissions on or before the hearing date,“ he said when contacted by Bernama today.

Lawyer Amir Farid Mohd Nawawi, representing Armin Zaharin, 56, when contacted, confirmed the matter.

Armin Zaharin filed an appeal petition at the High Court on Jan 4 against the conviction and sentence meted out by magistrate Sabreena Bakar @ Bahari last Sept 28.

She had found Armin Zaharin guilty of intentionally causing injuries and bruises to the hands of his nine-year-old son by using a cane at a house in Denai Alam, Shah Alam, between 8pm and 10.30pm on Feb 24, 2018.

The father of four was charged under Section 323 of the Penal Code which provides for a jail term of up to a year or a fine of RM2,000 or both, if convicted.

Sabreena, however, allowed the execution of the sentence to be postponed until the appeal process is completed but raised the bail from RM5,000 to RM8,000.

Armin Zaharin was arrested on March 2, 2018, after Ziana, whose real name is Siti Roziana Zin, 52, lodged a police report on Feb 27.

The couple, who married in 1998, is blessed with three sons and a daughter aged between 11 and 20.

They were divorced in July 2018. -Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings